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Background: Coronary heart disease remains the leading cause of death in developed countries. In Africa, the
disease continues to rise with varying rates of progression in different countries. At present, there is little available
work on its juvenile forms. The objective of this work was to study the epidemiological, clinical and evolutionary
aspects of acute coronary syndrome in young Sub-Saharan Africans.
Methods: This was a prospective multicenter study done at the different departments of cardiology in Dakar. We
included all patients of age 40 years and below, and who were admitted for acute coronary syndrome between
January 1st, 2005 and July 31st, 2007. We collected and analyzed the epidemiological, clinical, paraclinical and
evolutionary data of the patients.
Results: Hospital prevalence of acute coronary syndrome in young people was 0.45% (21/4627) which represented
6.8% of all cases of acute coronary syndrome admitted during the same period. There was a strong male
predominance with a sex-ratio (M:F) of 6. The mean age of patients was 34 ± 1.9 years (range of 24 and 40 years).
The main risk factor was smoking, found in 52.4% of cases and the most common presenting symptom was
chest pain found in 95.2% of patients. The average time delay before medical care was 14.5 hours. Diagnosis of
ST- elevation myocardial infarction in 85.7% of patients and non-ST-elevation myocardial infarction in 14.3% was
made by the combination electrocardiographic features and troponin assay. Echocardiography found a decreased
left ventricular systolic function in 37.5% of the patients and intraventricular thrombus in 20% of them. Thrombolysis
using streptokinase was done in 44.4% of the patients with ST- elevation myocardial infarction. Hospital mortality
was 14.3%.
Conclusion: Acute coronary syndrome is present in young Sub-Saharan Africans. The main risk factor found was
smoking.
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Coronary heart disease remains the leading cause of
death in developed countries. It is usually seen from the
fifth to the seventh decades of life, but some cases in
young people have been reported [1,2]. In Africa, while
the work of the first European doctors that arrived on
the continent claimed the low occurrence or even ab-
sence of atherosclerosis and its clinical manifestations,* Correspondence: bambandiaye75@yahoo.fr
1Service de Cardiologie, CHU Aristide Le Dantec University Hospital,
PO Box 6633, Dakar étoile, Avenue Pasteur, Dakar, Senegal
Full list of author information is available at the end of the article
© 2013 Sarr et al.; licensee BioMed Central Ltd
Commons Attribution License (http://creativec
reproduction in any medium, provided the ordifferent schools of cardiology have shown not only their
emergence, but especially their increase although at differ-
ent rates in different countries [3,4]. On the other hand,
few studies have been published on young people (5).
The objective of this work was to study the epidemio-
logical, as well as the clinical and evolutionary peculiar-
ities of acute coronary syndrome (ACS) in the young
Sub-Saharan Africans of age 40 years and below.Methods
This was a prospective multicenter study conducted at the
respective cardiology departments of Aristide Le Dantec. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Risk factors found in the study population
Risk factors Number %







Sarr et al. BMC Cardiovascular Disorders 2013, 13:118 Page 2 of 4
http://www.biomedcentral.com/1471-2261/13/118University Hospital, Grand Yoff General Hospital and
Principal Hospital of Dakar over a period of 31 months
(January 1st 2005 to July 31st 2007), in Dakar, Senegal.
All patients with an age of 40 years and below, admit-
ted for acute coronary syndrome on the basis of anginal
pain at rest, suggestive electrocardiographic changes and
elevated troponin I levels, were included. Patients with
more than 40 years of age, those with stable angina, and
those with semi-recent or sequel of coronary syndrome
were excluded from the study.
We studied data on age, gender, past history including
history of diabetes, hypertension, smoking, alcoholism,
sedentarism (less than 30 minutes or more of moderate-
intensity physical activity on most days of the week),
obesity; family history of coronary heart disease at a
young age (before 55 years in men and 65 years in
women), use of estrogen-progestin contraceptives, stable
angina and stress.
We sought the presence of chest pain, dyspnea and
gastrointestinal symptoms.
We also noted the time delay before admission, the man-
agement given, and the vital parameters (blood pressure,
heart rate, respiratory rate, temperature, body mass index).
All patients had a complete physical examination and
a laboratory assessment. Troponin I assay was done
using Architect STAT chemiluminescent microparticle
immunoassay (Abbot). The other tests included blood
glucose level on admission, total cholesterol and its
fractions, and triglycerides. On the ECG, we looked for
subepicardial or subendocardial lesion, subepicardial or
subendocardial ischemia, abnormal Q waves, rhythm
and conduction abnormalities. We have also looked for
signs of venous stasis on the chest x-ray and evaluated
using Doppler echocardiography (which was performed
during the first 24 hours of admission), the left ventricle
wall motion, left ventricular ejection fraction using
Simpson's biplanar method, and the presence of intra-
cavitary thrombus. Treatment modalities were evaluated
as well as evolution during hospitalization.
The study protocol was approved by the Ethics Com-
mittee of the Ministry of Health and Social Welfare,
Senegal (Comité d’éthique du Ministère de la Santé et
l’Action Sociale). A signed consent form was obtained
from each of the study participants.
The studied parameters were entered into an elec-
tronic questionnaire using Epi Info version 6.0 of the
World Health Organization. Data analysis was per-
formed using SPSS 15.0 (Statistical Package for Social
Sciences). Quantitative data were expressed as mean ±
standard deviation.
Results
Hospital prevalence of acute coronary syndrome in
young patients was 0.45% (21/4627), meaning 6.8%(21/309) of patients admitted for acute coronary syn-
drome during the same period. Eighteen patients (85.7%)
were males and three patients (14.3%) were females,
giving a ratio of 6:1. The mean age of patients was
34 ± 1.9 years with a range of 24 and 40 years. In
women, the mean age was 37 years and among men it
was 34 years.
The risk factors in our patients (Table 1) were domi-
nated by active smoking found in 11 patients (52.4%).
The average number of pack-years was 8.10 ± 2.3 and
ranged from 1 to 17 pack-years.
Five patients (23.8%) had no risk factors, seven pa-
tients (33.3%) had one risk factor and the remaining
patients (42.9%) had more than one.
Chest pain was present in 20 patients (95.2%). In 65%
of cases, it was typical anginal pain and inaugural in
70% of cases. The average time delay before medical
care was given was 14.5 hours, with extremes of 03 and
48 hours.
On admission, blood pressure was greater than or
equal to 140 and/or 90 mmHg in three patients (14.3%).
Average body mass index was 23.5 ± 1.5 kg / m2. No pa-
tient was found to be obese.
Systemic examination was strictly normal in 18 pa-
tients (95.2%). Three patients however showed signs of
left ventricular failure (Killip II).
Mean troponin I level found was 29 ± 40.9 ng/ml (0.01
to 401.6 ng/ ml). Two patients had levels below 0.05
ng/ml. Average blood glucose level was 1.2 ± 0.4 g/l
(0.6 to 3.83 g/l). It was found to be 1.24 g/l in 4 patients
(21%). Mean total cholesterol was 1.4 ± 0.2 g/l (0.85 to
2.58 g/l). Hypercholesterolaemia was present in two
patients, LDL cholesterol greater than 1.6 g/l in one
patient and HDL cholesterol less than 0.4 g/l in seven
patients (41.2%). Two patients had a triglyceride level
greater than 1.5 g/l.
Electrocardiogram revealed an acute coronary syndrome
with persistent ST-elevation in 18 patients (85.7%) and
non ST-elevation acute coronary syndrome in three pa-
tients (14.3%).
Topographically, the anterior and inferior territories
were the most represented and found respectively in 14
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right ventricle was observed in one patient. We also
noted two cases of ventricular tachycardia and complete
atrioventricular block in one patient.
Chest radiography showed a cardiomegaly in four
patients (21%). Doppler echocardiography revealed
impaired segmental kinetics in 12 patients (60%). The
mean ventricular ejection fraction was 52.2 ± 8.5%
(20-80%). Systolic dysfunction was found in six patients
and left ventricular thrombus in four.
Concerning treatment, thrombolysis using streptokin-
ase was performed in eight patients, accounting for
44.4% of patients with ST-elevation.
Low molecular weight heparin was used in 19 patients
(90.5%), aspirin in 20 patients (95.2%), clopidogrel in 7
patients (33.3%) beta blockers in 17 patients (81%),
angiotensin converting enzyme inhibitors in 17 patients
(81%), statins in 14 patients (66.7%) and analgesics in 13
patients (62%).
The evolution during hospitalization after a mean hos-
pital stay of 18.7 ± 4.5 days (1–37 days) was favorable in
18 patients (85.7%). Three deaths (14.3%) were recorded,
two of which were due to sudden death from ventricular
fibrillation and one due to cardiogenic shock.
Discussion
In our study, the prevalence of acute coronary syndrome
before age 40 was 0.45% with an incidence of 6.8% on all
patients with coronary heart disease hospitalized during
the same period.
Data on the incidence of acute coronary syndrome in
young people are rare in Africa [5,6]. However, Wade
found a prevalence of 0.03% and an incidence of 5.7% [7].
This incidence of 6.8% is bringing our numbers in the
range of the European and American literature (4-10%)
[8-12] and could be an evidence of a real epidemio-
logical transition.
The mean age of our patients was 34 years. Tricot
[13], and Dolder [8] found, respectively, a mean age of
36 years and 35.4 years. However in India the youngest
age reported for acute coronary syndrome was in a
14 year-old [14].
Our study confirms male predominance as has been
emphasized in previous works [2,7,9,10,14].
Smoking was found to be the main risk factor and is
often found in the occurrence of coronary events in
young patients [15]. Indeed, most works on the occur-
rence of coronary syndrome in young patients have a
disease pattern dominated by monotonous smoking
[9,16,17].
This is reflected in our work where smoking is found
in 52.4% of cases. This rate seems more important in
European series, where it has been reported to be up to
93% [13]. The use of hard drugs, as was the case withone of our patients, may be associated with the occur-
rence of a coronary event [18,19].
The delay in our work (14.5 hours) is close to what is
found in some Africans like in Tunisia [20].This period
is shorter in the European series [21,22].
Clinically, acute coronary syndrome in young patients
does not appear much different from that of the elderly.
This has been emphasized by several authors [9,14,23,24].
The picture of acute coronary syndrome is dominated by
pain in both the young as well as in the elderly.
Elevation of troponin levels form part of the definition
of acute coronary syndrome [25]. This high rate of
troponin assay in our work translates into a better inte-
gration of this biological parameter in the management
of acute coronary syndrome. Concerning cardiomegaly
found in 4 patients on chest X-ray at admission, no con-
clusion could be drawn as data on the existence cardio-
myopathies or other heart disease could be established.
In our study we found using Doppler echocardiog-
raphy an impaired left ventricular systolic function in
37.5% of cases versus 63.3% found by Renambot J et al.
However, the mean age of patients in this series was
47.1 years ± 4 [26]. Left intraventricular thrombus in the
apical region was found in 20% of our patients. These
results confirm data from the literature [27,28]. Segmen-
tal abnormality observed in only 60% of the cases might
be primarily the effect of thrombolytic therapy. Also the
degree of myocardial damage may not have been severe
enough to lead segmental abnormality.
The impact of thrombolytic therapy on mortality with
a time-dependent effect has been reported by several
studies [29-31]. It is now clear that thrombolysis can sig-
nificantly reduce mortality of patients with acute coron-
ary syndrome. In our work, steptokinase being the only
available thrombolytic in our hospitals, was used in
44.4% of patients admitted with an ST-elevation acute
coronary syndrome. The reasons for the low use of
thrombolytics in this study were due to many factors in-
cluding low awareness level of the population about
acute coronary syndrome, poor transport and communi-
cation network to reach referral centers, lack of available
electrocardiography in health centers which are located
close to patients, delayed referral from health centers of
suspected cases and inability to meet the high cost of
thrombolytic treatment. The favorable outcome in young
adults, as seen in our work (85.7%) seems higher than
that observed in the elderly.
Heart failure is a common and serious complication of
acute myocardial infarction. It was present in our work
in 14.3% of patients. This was found in 18.2% and 9.2%
respectively in the series of Al-Khadra and Kanitz
[14,24]. A relationship between age and heart failure has
been reported by Magid with a greater frequency of oc-
currence in the elderly compared to young subjects [32].
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30-40% of deaths occurring during the first 12 hours of
a myocardial infarction. In our work, ventricular fibrilla-
tion was responsible for two deaths during the acute
phase.
Conclusion
The occurrence of acute coronary syndrome is a reality
in young Sub-Saharan Africans. The main risk factor is
smoking. Complications are not rare and the mortality
remains high.
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